Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.
about
Progress of Research on Diffuse Axonal Injury after Traumatic Brain Injury.Treatment of Cervical Artery Dissection: Antithrombotics, Thrombolysis, and Endovascular TherapyAlpha-7 Nicotinic Receptor Signaling Pathway Participates in the Neurogenesis Induced by ChAT-Positive Neurons in the Subventricular Zone.Intranasal insulin neuroprotection in ischemic stroke.Sex differences in stroke therapiesDeciphering Brain Insulin Receptor and Insulin-Like Growth Factor 1 Receptor Signalling.Neuroprotective effect of hyperbaric oxygen therapy in a juvenile rat model of repetitive mild traumatic brain injuryParadigms and mechanisms of inhalational anesthetics mediated neuroprotection against cerebral ischemic stroke.Galanin Protects from Caspase-8/12-initiated Neuronal Apoptosis in the Ischemic Mouse Brain via GalR1.The relation between insulin-like growth factor 1 levels and risk of depression in ischemic stroke.Awake, long-term intranasal insulin treatment does not affect object memory, odor discrimination, or reversal learning in mice.Molecular hydrogen: a therapeutic antioxidant and beyondInsulin resistance in ischemic stroke.Hypoxia therapy--a new hope for the treatment of mitochondrial dysfunctions.The production of high dose hydrogen gas by the AMS-H-01 for treatment of disease.Sestrin2 induced by hypoxia inducible factor1 alpha protects the blood-brain barrier via inhibiting VEGF after severe hypoxic-ischemic injury in neonatal rats.Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.Insulin-like Growth Factor Binding Protein6 Associated with Neuronal Apoptosis Following Intracerebral Hemorrhage in Rats.The role of KATP channels in cerebral ischemic stroke and diabetes.Stem Cell Therapy and Administration Routes After Stroke.Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence.IGF-Binding Proteins: Why Do They Exist and Why Are There So Many?
P2860
Q31154284-FE0801E2-3196-42C1-9775-A6A598BC9642Q33760166-2B5B40BC-267E-4E3B-A3E7-DBEAD62188FCQ34557214-F33E2054-36EB-4DB3-9755-B91FC7172492Q36790800-F41B1FFB-7B28-4953-B7E0-3C49472741F7Q37445950-A3D6E8D0-1091-4C3F-8747-801DEBA2B139Q37456221-14F810F7-7676-4AE0-96E5-DD7A3827DC29Q37576181-FF7C5146-9A86-440F-ACEB-4CC7C1FEC855Q37576186-6AB8DB66-B64D-44CC-AEEE-EB588156F2E4Q37619218-8E96F098-EFAD-4241-B71F-11F8CFED0757Q38612105-F26CE234-5ABA-4FAF-87B9-821B06F48F8DQ38929334-B99170A4-EEEA-4FD4-8269-6C7EA0D7B437Q39143724-C099C913-9231-4630-8FD5-986CB0726E9AQ39387402-2FF7245A-0EB7-44A8-9FA3-1A7C1F51C6CAQ42368539-CCB9104E-69A0-4370-8A4C-5C8A8040E058Q42368544-E7745C42-C0AE-4BAD-9623-1A4A358ABCB8Q47136564-4EED4037-C68F-4AEB-A7F3-54EB7C690113Q48337519-272E9120-E9A2-40AF-A142-53E14F9BF91AQ48374789-8CDEFC9E-3352-4536-B9B6-510487480A34Q52316007-52E375D1-8FEE-4ADD-B439-6FD3EB975AF6Q54015446-238A857C-DE61-4D3F-B054-2D153E3C0A68Q55092215-2A16FB1A-9DC5-4F4E-ABB5-32F0ECE5B0BAQ55259134-59D5AB05-4C34-4924-9BB8-02CD61085055
P2860
Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Intranasal Insulin and Insulin ...... ants in Acute Ischemic Stroke.
@en
type
label
Intranasal Insulin and Insulin ...... ants in Acute Ischemic Stroke.
@en
prefLabel
Intranasal Insulin and Insulin ...... ants in Acute Ischemic Stroke.
@en
P2093
P2860
P1476
Intranasal Insulin and Insulin ...... ants in Acute Ischemic Stroke.
@en
P2093
Chen-Chih Chung
Daniela A Pimentel
Francisco Bedoya
Freddy Alfaro-Martinez
Vasileios-Arsenios Lioutas
Vera Novak
P2860
P2888
P304
P356
10.1007/S12975-015-0409-7
P577
2015-06-05T00:00:00Z